DEMO

Log In | Sign Up



Dechra Pharmaceuticals

Selected Articles

2025-07-21
GlobeNewswire
Veterinary Dermatology - Company Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion
Read More
2025-07-10
GlobeNewswire
[Latest] Global Pet Oral Care Products Market Size/Share Worth USD 3,583.11 Million by 2034 at a 5.73% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Read More
2025-07-08
GlobeNewswire
Equine Healthcare Market Research and Forecast Report 2025-2034 | Top Players Drive Innovations, Strategic Collaborations and Product Expansion on the Rise
Read More
2025-07-03
GlobeNewswire
$5 Bn Pet Supplements Market Trends, Analysis, and Forecasts 2025-2034 | AI-Driven Personalized Nutrition and CBD-Infused Supplements Transforming Pet Health
Read More
2025-06-30
GlobeNewswire
PetVivo Reports Fiscal 2025 Results
Read More
2025-06-27
GlobeNewswire
Companion Animal Health Market to Surpass USD 51.15 Billion by 2032 Due to Rising Pet Ownership and Advancements in Veterinary Care – SNS Insider
Read More
2025-06-24
PR Newswire UK
Pet Oral Care Market to Reach USD 3 Billion by 2032 at a CAGR of 6.1% from 2025 - Meticulous Research®
Read More
2025-06-02
GlobeNewswire
Anti-Parasite Products Market to Reach $18 Billion by 2034, Growing at 4.8% CAGR | Exactitude Consultancy
Read More
2025-04-23
GlobeNewswire
Companion Animal Arthritis Market to Surge by 62% by 2029, Driven by Aging Pet Population and Innovations in Veterinary Medicine
Read More
2025-04-02
GlobeNewswire
Analysis of the US$22.38 Billion Farm Animal Healthcare Market, 2025 - Bayer, C. H. Boehringer Sohn AG & Co., Ceva Sante Animale, Merck & Co., and Virbac Corp. Dominate
Read More

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, internal medicine, and nutrition products supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. It also provides water soluble antibiotics, vaccines, lameness, pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. In addition, the company distributes veterinary pharmaceuticals and equipment; markets pet diets; and develops, regulates, manufactures, and markets crop protection, as well as offers financial services. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom. As of January 16, 2024, Dechra Pharmaceuticals PLC was taken private. GB0009633180 www.dechra.com